Correlation of Fecal Calprotectin and Fecal Immunochemical Test in Determination of Endoscopic Activity in Inflammatory Bowel Disease Patients
NCT ID: NCT06623383
Last Updated: 2024-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
120 participants
OBSERVATIONAL
2024-10-01
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of the study is to investigate the correlation and efficacy of stool test results, calprotectin and fecal immunochemical test, compared to colonoscopy in patients with IBD.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remote Monitoring of IBD
NCT05886322
FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD)
NCT01676324
Value of Fecal Calprotectin
NCT00577928
Assessment of Non-invasive Tools for Detecting Active Inflammatory Bowel Disease
NCT06722456
Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD
NCT02197780
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with inflammatory bowel disease, either ulcerative colitis or Crohn's disease.
* Scheduled for colonoscopy for various indications, including:
1. Follow-up after treatment to assess disease remission
2. Clinical symptoms or laboratory results suggesting disease flare, such as increased abdominal pain, more frequent diarrhea, or elevated inflammatory markers in the blood
3. Screening for colorectal cancer in patients with long-standing inflammatory bowel disease.
Exclusion Criteria
* Failure to provide stool samples.
* Patients hospitalized for reasons unrelated to inflammatory bowel disease.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahidol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Julajak Limsrivilai
Associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine, Siriraj Hospital, Mahidol University
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
579/2566(IRB2)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.